Text states 'When Mr. Hugin arrived at Celgene in June 1999...'
HOUSE_OVERSIGHT_028417.jpg
This document is a data extract, likely from a news article, which has been marked as an exhibit for a House Oversight investigation. The text details the history of the pharmaceutical company Celgene and its drug Thalomid (thalidomide), including its approval by the F.D.A. in 1998 and the context of executive Bob Hugin's subsequent political career. The document contains no information related to Jeffrey Epstein or his associates.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship